fda approves deflazacort for duchenne muscular dystrophy
Published 7 years ago • 8.4K plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:40
mda celebrates new fda drug approval for duchenne muscular dystrophy
-
2:12
fda approved gene therapy | duchenne muscular dystrophy
-
3:27
cure rare disease has received fda approval for its first duchenne muscular dystrophy therapeutic
-
8:54
use of corticosteroids in dmd management
-
9:26
fda approves new drug for dmd patients despite its ineffectiveness
-
2:09
gene therapy for duchenne muscular dystrophy gets fda approval
-
52:23
community webinar series 2021: advancements in duchenne drug development and fda approved therapies
-
3:17
eteplirsen is granted accelerated approval in us
-
1:12:58
potential biomarkers and new therapies for duchenne muscular dystrophy
-
1:02
fda approves first gene therapy for muscular dystrophy: a major step forward
-
4:55
marathon pharmaceuticals charging $89,000 for muscular dystrophy drug
-
4:06
episode 20: duchenne muscular dystrophy
-
49:00
therapeutic approaches in dmd – craig mcdonald, md, professor of pediatrics, uc davis health
-
23:04
marathon pharmaceuticals (deflazacort) [ppmd's 2015 connect conference]
-
28:25
[webinar] deflazacort access: navigating potential changes to your prescription - november 2016
-
1:04
ataluren, deflazacort, and duchenne muscular dystrophy
-
46:40
duchenne muscular dystrophy drug development roundtable
-
13:20
approved therapies - ptc therapeutics
-
1:28
emflaza (deflazacort)- duchenne muscular dystrophy (dmd)